43237748 2023-01-01 2023-12-31 43237748 2023-01-01 2023-12-31 1 43237748 2023-01-01 2023-12-31 0 43237748 2023-01-01 2023-12-31 2 43237748 2022-05-04 2022-12-31 43237748 2023-12-31 43237748 2022-12-31 iso4217:DKK Annual report 2024-04-10 Dayanand Jadhav G2B BioSolutions Denmark ApS Hagens Alle 7 2900 Hellerup 43237748 2023-01-01 2023-12-31 CROWE STATSAUTORISERET REVISIONSINTERESSENTSKAB Rygårds Allé 104 2900 Hellerup <p xmlns="http://www.w3.org/1999/xhtml">Management has today considered and approved the annual report for the financial year 01. January 2023 - 31. December 2023 for G2B BioSolutions Denmark ApS.</p> <p xmlns="http://www.w3.org/1999/xhtml"> </p> <p xmlns="http://www.w3.org/1999/xhtml">The annual report is presented in accordance with the Danish Financial Statements Act.</p> <p xmlns="http://www.w3.org/1999/xhtml"> </p> <p xmlns="http://www.w3.org/1999/xhtml">Management believes that the financial statements give a true and fair view of the company's assets, liabilities and financial position and of the result.</p> <p xmlns="http://www.w3.org/1999/xhtml"> </p> <p xmlns="http://www.w3.org/1999/xhtml">The annual report is submitted for approval by the General Assembly.</p> Management considers the conditions for opting out of audit to be met. Hellerup 2024-04-04 Dayanand Suryabhan Jadhav Auditor's reports To the shareholder of G2B BioSolutions Denmark ApS We have compiled the financial statements of G2B BioSolutions Denmark ApS for the financial year 1. january 2022 - 31. december 2022 based on the company's bookkeeping records and other information made available by enterprise. The financial statements comprises a summary of significant accounting policies, income statement, balance sheet and notes. We performed the engagement in accordance with ISRS 4410, Compilation Engagements. We have applied our professional expertise to assist the enterprise in the preparation and presentation of the financial statements in accordance with the Danish Financial Statements Act. We complied with the relevant provisions of the Danish Act on Approved Auditors and with the International Ethics Standards Board for Accountants' Code of Ethics for Professional Accountants (IESBA Code), including principles relating to integrity, objectivity, professional competence and due care. The financial statements and the accuracy and completeness of the information used to compile the financial statements are the enterprise´s responsibility. As a compilation engagement is not an assurance engagement, we are not required to verify the accuracy or completeness of the information provided by enterprise for our compilation of the financial statements. Accordingly, we do not express an audit or a review conclusion on whether the financial statements have been prepared in accordance with the Danish Financial Statements Act. Hellerup 2024-04-04 Crowe Statsautoriseret Revisionsinteressentskab v.m.b.a 33256879 Søren Jonassen mne18488 Statsautoriseret revisor <p xmlns="http://www.w3.org/1999/xhtml"> <strong>Major Activities</strong> <br/> The company has been without activities in the financial year. <br/>   <br/> <strong>Reasons for any major changes in your Company's activities or economy</strong> <br/> The year's result in 2023 is DKK -10.098. The year's result is considered satisfactory. <br/>   <br/> <strong>Events after the end of the financial year (Optional)</strong> <br/> After the end of the financial year, no events have occurred that could materially affect the company's financial position.</p> The annual report has been prepared in accordance with the regulation applying to Reporting class B. Reporting class B <p xmlns="http://www.w3.org/1999/xhtml"> <strong>Basis of recognition and measurement</strong> <br/> <br/> Income is recognised in the income statement as earned, including value adjustments of financial assets and liabilities. All expenses, including amortisation, depreciation and impairment losses, are also recognised in the income statement. <br/>  </p> <p xmlns="http://www.w3.org/1999/xhtml">Assets are recognised in the balance sheet when it is probable that future economic benefits will flow to the company and the value of the asset can be measured reliably. Liabilities are recognised in the balance sheet when it is probable that future economic benefits will flow from the company and the value of the liability can be measured reliably. On initial recognition, assets and liabilities are measured at cost. On subsequent recognition, assets and liabilities are measured as described below for each individual accounting item. <br/>  </p> <p xmlns="http://www.w3.org/1999/xhtml">Certain financial assets and liabilities are measured at amortised cost using the effective interest method. Amortised cost is calculated as the historic cost less any installments and plus/less the accumulated amortisation of the difference between the cost and the nominal amount. <br/>  </p> <p xmlns="http://www.w3.org/1999/xhtml">On recognition and measurement, allowance is made for predictable losses and risks which occur before the annual report is presented and which confirm or invalidate matters existing at the balance sheet date. <br/>  </p> <p xmlns="http://www.w3.org/1999/xhtml"> <strong>Balance sheet</strong> <br/>  </p> <p xmlns="http://www.w3.org/1999/xhtml"> <strong>Receivables</strong> <br/>  </p> <p xmlns="http://www.w3.org/1999/xhtml">Receivables are measured at amortised cost. <br/>  </p> <p xmlns="http://www.w3.org/1999/xhtml">An impairment loss is recognised if there is objective evidence that a receivable or a group of receivables is impaired. If there is objective evidence that an individual receivable is impaired, an impairment loss for that individual asset is recognised. <br/>  </p> <p xmlns="http://www.w3.org/1999/xhtml"> <strong>Liabilities</strong> <br/>  </p> <p xmlns="http://www.w3.org/1999/xhtml">Liabilities, which include trade payables, payables to group entities and other payables, are measured at amortised cost, which is usually equivalent to nominal value.</p> -10098 0 -10098 0 0 0 -10098 0 0 0 -10098 0 -10098 0 -10098 0 0 40000 0 40000 34902 0 34902 40000 34902 40000 40000 40000 -10098 0 29902 40000 5000 0 5000 0 5000 0 34902 40000 <p xmlns="http://www.w3.org/1999/xhtml">The company is jointly taxed with its  parent company, Dayanad Jadhav Holding ApS (management company), and G2B BioSolutions ApS, and jointly and severally liable with other jointly taxed entities for payment of income taxes as well as for payment of withholding taxes on dividends which fall due for payment on.</p> <p xmlns="http://www.w3.org/1999/xhtml">The company has no other contingent liabilities.</p> <table xmlns="http://www.w3.org/1999/xhtml" class="incomeStatement" style="border:0; margin-bottom: 20px;"> <thead> <tr class="header1"> <th class="col1"/> <th class="col2"/> <th class="col3">2023</th> </tr> </thead> <tbody> <tr> <td class="col1 dotted"> <span> Average number of employees </span> </td> <td class="col2"> </td> <td class="col3"> 1 </td> <td class="col4 lastyear"> </td> </tr> </tbody> </table> 1 false false false true Erhvervsstyrelsen Regnskab Basis 2022-12-31 2022-05-04 Auditor's reports (Other non-assurance reports) Crowe Rygårds Allé 104 2900 Hellerup